Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group Co's quarterly market cap
declined
from Jun. 2025 (HK$825 Mil) to Dec. 2025 (HK$815 Mil) but then
increased
from Dec. 2025 (HK$815 Mil) to Jun. 2026 (HK$1,030 Mil).
Yonghe Medical Group Co's annual market cap
declined
from Dec. 2023 (HK$1,270 Mil) to Dec. 2024 (HK$450 Mil) but then
increased
from Dec. 2024 (HK$450 Mil) to Dec. 2025 (HK$815 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Yonghe Medical Group Co's Enterprise Value for Today is HK$659 Mil.
Yonghe Medical Group Co (HKSE:02279) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Yonghe Medical Group Co Market Cap Related Terms
Yonghe Medical Group Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02279 vs HCA, THC, DVA: Market Cap Comparison
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Yonghe Medical Group Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yonghe Medical Group Co (HKSE:02279) has a Market Cap of HK$1,245 Mil as of Aug. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Yonghe Medical Group Co and its competitors. According to the industry distribution chart, Yonghe Medical Group Co ranks #308 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 44.6%.
Is Yonghe Medical Group Co's Market Cap too high?
Yonghe Medical Group Co's current Market Cap is HK$1,245 Mil. Based on the distribution chart, Yonghe Medical Group Co ranks #308 out of 690 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #308 out of 690 companies for Market Cap. This puts Yonghe Medical Group Co in the upper half of its industry. The industry median Market Cap is 107.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 107.56, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 107.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current Market Cap is HK$1,245 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yonghe Medical Group Co (HKSE:02279) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.01, compared to a current price of HK$2.49 — trading 23.9% above its estimated fair value. The current Market Cap is HK$1,245 Mil. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Yonghe Medical Group Co (HKSE:02279), the current Market Cap is HK$1,245 Mil as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (HKSE:02279) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of HK$2.49 is trading 23.9% above its estimated GF Value™ of HK$2.01.
GuruFocus considers Yonghe Medical Group Co to be Modestly Overvalued.
Key valuation signals for HKSE:02279:
Market Cap: HK$1,245 Mil
GF Value™: HK$2.01 vs. price of HK$2.49 (23.9% above fair value)
No single metric tells the full story. See the HKSE:02279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for HKSE:02279
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02279 has been successfully added to your 
